Hye Jin Jang

1.0k citations
23 papers · 798 indexed · h-index 11
Topics
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers)COVID-19 Clinical Research Studies (3 papers)Sarcoidosis and Beryllium Toxicity Research (3 papers)

In The Last Decade

Hye Jin Jang

21 papers receiving 792 citations

Peers

Hye Jin Jang
Comparison fields: 5 of 86
  • Molecular Biology 408
  • Pulmonary and Respiratory Medicine 345
  • Cancer Research 274
  • Oncology 180
  • Rheumatology 60
Replace Jun Xiao with:
Jun Xiao China
Yongfu Xiong China
Patrick M. Lec United States
Shulamit B. Wallach‐Dayan Israel
Peihua Liu China
Marco Giallombardo Belgium
Yusha Xiao China
Hye Jin Jang relative to Jun Xiao China Jun Xiao's profile →
Citations per field
00.5×1.5×1.9×
Jun Xiao · 1×
Citations per year

Countries citing papers authored by Hye Jin Jang

Since Specialization
Citations

This map shows the geographic impact of Hye Jin Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hye Jin Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hye Jin Jang more than expected).

Fields of papers citing papers by Hye Jin Jang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hye Jin Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hye Jin Jang. The network helps show where Hye Jin Jang may publish in the future.

Co-authorship network of co-authors of Hye Jin Jang

This figure shows the co-authorship network connecting the top 25 collaborators of Hye Jin Jang. A scholar is included among the top collaborators of Hye Jin Jang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hye Jin Jang. Hye Jin Jang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 3
4 2
5 0
6 9
7 9
8 5
9 54
10 35
11 10
12 15
13 40
14 307
15 45
16 68
17 92
18 12
19 5
20
Anti inflammatory Activity of Codium fragile in Macrophages Induced by Peptidoglycan
1

About Hye Jin Jang

Hye Jin Jang is a scholar working on Microbiology, Internal Medicine and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 798 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), COVID-19 Clinical Research Studies (3 papers) and Sarcoidosis and Beryllium Toxicity Research (3 papers). The work is most often cited by research in Cancer Research (274 citations), Pulmonary and Respiratory Medicine (345 citations) and Oncology (180 citations). Hye Jin Jang has collaborated with scholars based in South Korea, Ethiopia and United States. Frequent co-authors include Jong‐Lyel Roh, Eun Hye Kim, Jin Young Park, Daiha Shin, Eun Hye Kim, Kwan Sik Seo, Minsu Kwon, Taiho Park, Sang Hoon Lee and Ji Hoon Jeong. Their work appears in journals such as Oncogene, Chemical Communications and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026